Liver immunology
The liver is a central immunological organ with a high exposure to circulating antigens and endotoxins from the gut micro biota, particularly amended for ingrain vulnerable cells( macrophages, ingrain lymphoid cells, mucosal- associated steady T( MAIT) cells). The liver is a key, frontline vulnerable towel. Immaculately deposited to descry pathogens entering the body via the gut, the liver appears designed to descry, prisoner, and clear bacteria, contagions, and macromolecules.
Related Conference of Liver immunology
October 19-20, 2026
25th International Conference on Gastroenterology and Digestive Disorders
Rome, Italy
Liver immunology Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- Advances in Medical Imaging - Gastrosummit 2027 (France)
- Celiac Disease - Gastrosummit 2027 (France)
- Colorectal Diseases - Gastrosummit 2027 (France)
- Diagnostic Biomarkers and Therapeutic Targets in Digestive Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Digestive System Cancers - Gastrosummit 2027 (France)
- Digestive System Cancers - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Endoscopy and Minimally Invasive Gastrointestinal Procedures - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Esophageal Disorders - Gastrosummit 2027 (France)
- Esophageal Disorders - Gastrosummit 2027 (France)
- Gastric Diseases and Peptic Ulcers - Gastrosummit 2027 (France)
- Gastric Diseases and Peptic Ulcers - Gastrosummit 2027 (France)
- Gastrointestinal Bleeding - Gastrosummit 2027 (France)
- Gastrointestinal Disorders and Treatment - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Infections and Immunity - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Oncology and Tumor Biology - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Pharmacology - Gastrosummit 2027 (France)
- Gastrointestinal Surgery - Gastrosummit 2027 (France)
- Geriatric Gastroenterology - Gastrosummit 2027 (France)
- Gut Microbiota and Gastrointestinal Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gut Microbiota and Metabolic Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Hepatology: Liver Disease and Transplantation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Inflammatory Bowel Disease (IBD) - Gastrosummit 2027 (France)
- Inflammatory Bowel Disease and Intestinal Inflammation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Inflammatory Bowel Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver and Pancreatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Diseases and Hepatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Diseases and Hepatology - Gastrosummit 2027 (France)
- Liver Transplantation - Gastrosummit 2027 (France)
- Non-Alcoholic Fatty Liver Disease - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Nutrition and Aging: Geriatric Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Nutrition in Digestive Health - Gastrosummit 2027 (France)
- Pancreatic Diseases - Gastrosummit 2027 (France)
- Pancreaticobiliary Disorders - Gastrosummit 2027 (France)
- Pediatric and Adolescent Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pediatric Gastroenterology - Gastrosummit 2027 (France)
- Pediatric Gastroenterology and Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Peptic Ulcer and Acid-related Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Plant-Based Nutrition and Sustainable Diets - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Precision Medicine in Digestive Diseases - Gastrosummit 2027 (France)
- Role of Microbiota in Digestive Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Viral Hepatitis - Gastrosummit 2027 (France)